Article Menu

Export Article

More by Authors Links

Article Data

  • Views 183
  • Dowloads 145

This is a correction to: European Journal of Gynaecological Oncology. 2025; 46(10): 21-30. https://doi.org/10.22514/ejgo.2025.128

Corrections

Open Access

Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer

  • Numan Comert1
  • Ozge Sukruoglu Erdogan2
  • Betul Celik Demirbas2
  • Seda Kilic Erciyas2
  • Ahmet Dinc1
  • Özge Pasin3
  • Hülya Yazıcı4
  • Seref Bugra Tuncer2,*,

1Institute of Graduate Studies in Health Sciences, Istanbul University, 34126 Istanbul, Türkiye

2Department of Cancer Genetics, Oncology Institute, Istanbul University, 34093 Istanbul, Türkiye

3Department of Biostatistics and Medical Informatics, Hamidiye Medical Faculty, Health Sciences University, 34668 Istanbul, Türkiye

4Department of Medical Biology, Faculty of Medicine, Istanbul Health and Technology University, 34275 Istanbul, Türkiye

DOI: 10.22514/ejgo.2026.036 Vol.47,Issue 3,October 2026 pp.130-131

Published: 15 October 2026

*Corresponding Author(s): Seref Bugra Tuncer E-mail: seref.tuncer@istanbul.edu.tr

PDF (267.85 kB) View Full-text

Cite and Share

Numan Comert, Ozge Sukruoglu Erdogan, Betul Celik Demirbas, Seda Kilic Erciyas, Ahmet Dinc, Özge Pasin, Hülya Yazıcı, Seref Bugra Tuncer. Correction: PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer. European Journal of Gynaecological Oncology. 2026; 47(3): 130-131. doi: 10.22514/ejgo.2026.036

URL:

https://www.ejgo.net/articles/10.22514/ejgo.2026.036

References

[1] Comert N, Sukruoglu Erdogan O, Celik Demirbas B, Kilic Erciyas S, Dinc A, PasinÖ, et al. PRDM6 promoter methylation as a potential epigenetic biomarker in BRCA-associated ovarian cancer. European Journal of Gynaecological Oncology. 2025; 46: 21–30.

Submission Turnaround Time

Top